Showing results (691-700 of 1,005) with videos related to

Sort By:
Pageof 101
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 6, 2023
Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation PhaseHussein Awada, Adel Hajj Ali, Faiz Anwer, et al.
Inhalation Toxicology|April 23, 2026
Exposure to electronic cigarette aerosols triggers alterations in genomic DNA methylation that impacts cancer pathways in miceChristina Awada, Catherine B Klein, Terry Gordon, et al.
British Journal of Cancer|May 6, 2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyA Awada, J Albanell, P A Canney, et al.
Foods (Basel, Switzerland)|March 13, 2024
<i>Cymbopogon winterianus</i> (Java Citronella Plant): A Multi-Faceted Approach for Food Preservation, Insecticidal Effects, and Bread ApplicationMarwa Rammal, Adnan Badran, Chaden Haidar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2024
Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancerTheresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, et al.
Research in Veterinary Science|May 17, 2024
Identification of risk factors on rabies vaccine efficacy from censored data: Pre-travel tests for dogs and cats from Yaoundé (2005-2015)François Ntsama, Susan M Noh, Paolo Tizzani, et al.
Seminars in Oncology|October 1, 1996
An ongoing European organization for research and treatment of cancer crossover trial comparing single-agent paclitaxel and doxorubicin as first- and second-line treatment of advanced breast cancerM J Piccart-Gebhart, P Bruning, T Gamucci, et al.
The Lancet. Oncology|April 28, 2009
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II studyBella Kaufman, Maureen Trudeau, Ahmad Awada, et al.
Breast Cancer Research and Treatment|November 15, 2015
Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialJavier Cortes, Stacie Hudgens, Chris Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapyA Awada, L Dirix, L Manso Sanchez, et al.
Pageof 101